What Next for Voyager Therapeutics Inc (VYGR) After Forming Bearish Wedge Down Pattern?

July 17, 2017 - By Nellie Frank

The stock of Voyager Therapeutics Inc (VYGR) formed a down wedge with $9.30 target or 4.00 % below today’s $9.69 share price. The 9 months wedge indicates high risk for the $261.82M company. If the $9.30 price target is reached, the company will be worth $10.47M less.
Falling wedges are poor performers for bullish breakouts and are tricky moments to trade. Investors must be aware that the break even failure rate for up or down breakouts is: 11% and 15%. The average rise is 32% and the decline is 15%. The falling wedges has high throwback and pullback rate: 56%, 69% and the percent of wedges meeting target is not very high.

About 25,404 shares traded. Voyager Therapeutics Inc (NASDAQ:VYGR) has declined 18.89% since July 17, 2016 and is downtrending. It has underperformed by 35.59% the S&P500.

Voyager Therapeutics Inc (NASDAQ:VYGR) Ratings Coverage

Among 6 analysts covering Voyager Therapeutics (NASDAQ:VYGR), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Voyager Therapeutics had 7 analyst reports since December 7, 2015 according to SRatingsIntel. The company was initiated on Monday, December 7 by Piper Jaffray. Cowen & Co initiated the stock with “Outperform” rating in Monday, December 7 report. The company was initiated on Friday, May 20 by Wells Fargo. The stock has “Neutral” rating by Chardan Capital Markets on Monday, January 25. On Friday, July 15 the stock rating was initiated by Stifel Nicolaus with “Buy”. The rating was initiated by Chardan Capital Markets with “Sell” on Wednesday, December 9. The company was initiated on Monday, December 7 by Wedbush.

More notable recent Voyager Therapeutics Inc (NASDAQ:VYGR) news were published by: Globenewswire.com which released: “Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to …” on November 29, 2016, also Seekingalpha.com with their article: “Voyager Therapeutics’ (VYGR) CEO Steven Paul on Q4 2016 Results – Earnings …” published on March 15, 2017, Seekingalpha.com published: “Voyager Therapeutics: Poised For Gains In 2017” on January 26, 2017. More interesting news about Voyager Therapeutics Inc (NASDAQ:VYGR) were released by: Globenewswire.com and their article: “Voyager Therapeutics Announces Clinical Trial Update with VY-AADC01 for …” published on June 26, 2017 as well as Marketwatch.com‘s news article titled: “Voyager Therapeutics’ stock soars after Parkinson’s disease treatment’s …” with publication date: December 08, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.